Introduction Seminar About Patient Participation and Treatment Options for Psychiatric Patients on Waiting List

Brief Summary

Official Title: “Introduction Seminar About Patient Participation and Treatment Options for Patients on Waiting List in a Community Mental Health Centre – Development, Effect, Experiences and Costs”

Patient participation is a central concept in Norwegian health policy. It is mandatory in hospitals and emphasised as one of the most prioritised areas by the Government. Studies from Norway have repeatedly found that patients who seek help in community mental health centres ("DPS") are dissatisfied with the information they receive and about their possibility for real influence in their treatment.

One way to improve individual patient participation might be to give patients information before they start their treatment. This can be done as group based patient education to reduce the resources needed. Furthermore, as there are waiting lists for treatment, such introduction seminars could be held while patients are waiting to use this time in a meaningful way.

The present study therefore aims at testing the effect of an introduction seminar for patients on waiting list in a community mental health centre.

  • Study Type: Interventional
  • Study Design: Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment
  • Study Primary Completion Date: June 2011

Interventions Used in this Clinical Trial

  • Behavioral: Introduction seminar
    • The seminar will be held over two half days, each lasting 2.5 hours. Up to 30 patients can participate in each seminar. The details of the content of the program will be developed based on study one. The preliminarily plans are to give general information about the community mental health centre, the available treatment options and patients rights by presentations from health personnel and user representatives. At the end of each day, the patients will be divided into small groups mentored by health personnel were they can discuss the presentations and ask questions. In the breaks, literature and other type of information for patients will be on display. All participants will get a folder with details of the program and leaflets from patient organisations and governmental agencies.
  • Other: Usual care
    • Usual care

Arms, Groups and Cohorts in this Clinical Trial

  • Experimental: Introduction seminar
    • Psychoeducation for patients on waiting list
  • Active Comparator: Usual care
    • Usual care

Outcome Measures for this Clinical Trial

Primary Measures

  • Behavior and symptoms
    • Time Frame: 12 months
      Safety Issue?: No
  • knowledge on treatment preference
    • Time Frame: 1 month
      Safety Issue?: No
  • patient activation (coping)
    • Time Frame: 4 months
      Safety Issue?: No

Secondary Measures

  • Client satisfaction
    • Time Frame: Baseline, 4 and 12 months
      Safety Issue?: No
  • Perceived participation
    • Time Frame: Baseline, 4 and 12 months
      Safety Issue?: No
  • Psychiatric Out-Patient Experiences
    • Time Frame: Baseline, 4 and 12 months
      Safety Issue?: No
  • Quality of Life
    • Time Frame: Baseline, 4 and 12 months
      Safety Issue?: No
  • motivation for treatment
    • Time Frame: Baseline, 1 and 4 months
      Safety Issue?: No
  • costs
    • Time Frame: Baseline, 1, 4 and 12 months
      Safety Issue?: No
  • Knowledge
    • Time Frame: Baseline, 1, 4 and 12 months
      Safety Issue?: No

Criteria for Participation in this Clinical Trial

Inclusion Criteria

  • Patients older than 18 years referred for out patient treatment who get a guarantee of starting treatment between 2 and 6 months will be included.

Exclusion Criteria

  • patients with a guarantee of starting treatment in less than two months and
  • patients who do not understand the consequences of taking part in the study

Gender Eligibility for this Clinical Trial: Both

Minimum Age for this Clinical Trial: 18 Years

Maximum Age for this Clinical Trial: 65 Years

Are Healthy Volunteers Accepted for this Clinical Trial: No

Clinical Trial Investigator Information

  • Lead Sponsor
    • Norwegian University of Science and Technology
  • Collaborator
    • The Royal Norwegian Ministry of Health
  • Provider of Information About this Clinical Study
    • Sponsor
  • Overall Official(s)
    • Aslak Steinsbekk, PhD, Principal Investigator, Norwegian University of Science and Technology

Source

Clinical Trials content is provided directly by the US National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of information about a specific clinical trial contains a unique identifier which can be used to find further details directly from the National Institutes of Health.

The URL of this page is:
http://clinicaltrialsfeeds.org/clinical-trials/show/NCT00967265